Haemophilus influenzae is a human-specific gram-negative coccobacillus that causes a variety of human infections ranging from localized respiratory infections to invasive diseases. Hsf is the major nonpilus adhesin in encapsulated strains of H. influenzae and belongs to the trimeric autotransporter family of proteins. The Hsf protein contains two highly homologous binding domains, designated HsfBD1 and HsfBD2. In this study we characterized the differential binding properties of HsfBD1 and HsfBD2. In assays using HeLa cells, we found that bacteria expressing either full-length Hsf or HsfBD1 by itself adhered at high levels, while bacteria expressing HsfBD2 by itself adhered at low levels. Immunofluorescence microscopy and a cellular enzymelinked immunosorbent assay using purified proteins revealed that the binding affinity was significantly higher for HsfBD1 than for HsfBD2. Purified HsfBD1 was able to completely block adherence by bacteria expressing either HsfBD1 or HsfBD2, while purified HsfBD2 was able to block adherence by bacteria expressing HsfBD2 but had minimal activity against bacteria expressing HsfBD1. 
Haemophilus influenzae is a human-specific gram-negative coccobacillus that causes a variety of human infections ranging from localized respiratory infections to invasive diseases. Hsf is the major nonpilus adhesin in encapsulated strains of H. influenzae and belongs to the trimeric autotransporter family of proteins. The Hsf protein contains two highly homologous binding domains, designated HsfBD1 and HsfBD2. In this study we characterized the differential binding properties of HsfBD1 and HsfBD2. In assays using HeLa cells, we found that bacteria expressing either full-length Hsf or HsfBD1 by itself adhered at high levels, while bacteria expressing HsfBD2 by itself adhered at low levels. Immunofluorescence microscopy and a cellular enzymelinked immunosorbent assay using purified proteins revealed that the binding affinity was significantly higher for HsfBD1 than for HsfBD2. Purified HsfBD1 was able to completely block adherence by bacteria expressing either HsfBD1 or HsfBD2, while purified HsfBD2 was able to block adherence by bacteria expressing HsfBD2 but had minimal activity against bacteria expressing HsfBD1. Haemophilus influenzae is a gram-negative coccobacillus that causes both serious invasive diseases and localized respiratory tract infections in humans (10, 17, 19) . Isolates of H. influenzae can be separated into encapsulated and nonencapsulated or so-called nontypeable strains (12) . Most strains recovered from patients with invasive disease are encapsulated and express the type b capsule, while the majority of strains associated with respiratory tract infections are nontypeable (19) .
The pathogenesis of disease due to H. influenzae type b begins with colonization of the upper respiratory tract (4, 8, 11, 13, 16, 19) . Most type b strains are capable of expressing hemagglutinating pili, which mediate bacterial attachment to oropharyngeal epithelial cells, extracellular matrix proteins, and mucin and promote colonization. Mutant strains that lack hemagglutinating pili are also capable of adherence and colonization, highlighting the fact that nonpilus adhesive factors also exist (4, 5, 8, 20) . In recent work, we have demonstrated that the major nonpilus adhesin in H. influenzae type b is a large protein called Hsf, which forms short fibers visible by electron microscopy (15) .
The Hsf adhesin is encoded by the hsf locus and is a trimeric autotransporter protein that shares significant homology with Hia, a trimeric autotransporter adhesin that is present in ϳ25% of nontypeable H. influenzae strains. Hsf contains an N-terminal signal sequence, an internal passenger domain with two binding domains, and a C-terminal outer membrane poreforming domain, analogous to Hia (3, 6) . The binding domains in Hsf are called HsfBD1 and HsfBD2 and share high-level homology with each other and with the two binding domains in Hia (2, 14) . HsfBD1 and HsfBD2 interact with the same host cell receptor structure on Chang epithelial cells, although with different affinities (3) . Based on in vitro experiments using purified proteins and Chang epithelial cells, HsfBD1 has a dissociation constant (K d ) of ϳ0.2 nM and HsfBD2 has a K d of ϳ2.5 nM.
In previous work using X-ray crystallography and site-directed mutagenesis, we established that both HiaBD1 and HiaBD2 are trimeric structures with acidic binding pockets formed by contiguous IsNeck and Trp-ring domains (9, 21) . Using structural modeling and site-directed mutagenesis, we determined that HsfBD1 and HsfBD2 possess the same fold and trimeric assembly as HiaBD1 and HiaBD2, with conservation of the residues that are essential for HiaBD1 adhesive activity (3) .
In the current study we examined the structural basis for the different binding affinities of HsfBD1 and HsfBD2. In initial experiments, we found that the differences between HsfBD1 and HsfBD2 were easier to observe with HeLa cells than with Chang cells, reflecting the fact that the receptor density is lower on HeLa cells. Our results demonstrated the critical role of a single amino acid in the core of the binding pocket in determining the relative affinities of HsfBD1 and HsfBD2.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Bacterial strains and plasmids are listed in Table 1 . Escherichia coli strains were grown on Luria-Bertani (LB) agar or in LB broth and were stored at Ϫ80°C in LB broth with 30% glycerol. H. influenzae strains were grown on chocolate agar or in brain heart infusion broth supplemented with hemin and NAD (1) and were stored at Ϫ80°C in brain heart infusion broth with 30% glycerol. Selection for plasmids in E. coli strains was performed using ampicillin at a concentration of 100 g/ml.
In order to generate pNS1/HsfBD1 and pNS1/HsfBD2, DNA corresponding to Hsf residues 1899 to 2031 (HsfBD1) and 532 to 661 (HsfBD2) was amplified by PCR from pDC601, engineering BamHI and KpnI sites at the 5Ј and 3Ј ends, respectively. The resulting fragments were digested with BamHI and KpnI and then ligated into BamHI-KpnI-digested pNS1. Plasmids with point mutations in HsfBD1 and HsfBD2 were generated by performing site-directed mutagenesis on pNS1/HsfBD1 or pNS1/HsfBD2, as appropriate, using a QuikChange XL site-directed mutagenesis kit (Stratagene) according to the manufacturer's directions. Similarly, glutathione S-transferase (GST) expression constructs with mutations in HsfBD1 and HsfBD2 were generated by performing site-directed mutagenesis on pGEX-6-P-1/HsfBD1 or pGEX-6-P-1/HsfBD2, as appropriate. Mutagenized plasmids were confirmed to have the intended mutations by nucleotide sequencing.
Purification of GST fusion proteins. GST fusion proteins were purified as described previously (3) . Briefly, E. coli BL21(DE3) strains harboring pGEX-6P-1 derivatives were grown at 37°C in LB medium containing 100 g/ml ampicillin to an optical density at 600 nm of ϳ0.4 to 0.5. Cultures were then induced with isopropryl-␤-D-thiogalactopyranoside (IPTG) at a concentration of 0.1 mM for 3 h at 30°C. Bacteria were harvested by centrifugation at 6,600 ϫ g, resuspended in lysis buffer (phosphate-buffered saline [PBS], 5 mM EDTA, 1:100 Complete Mini protease inhibitor cocktail [Roche]), and lysed by sonication. Cell fragments were removed by centrifugation at 10,000 ϫ g, and GST fusion proteins were isolated by affinity chromatography using immobilized glutathione (Pierce) according to the manufacturer's directions.
Quantitative adherence assays. Chang epithelial cells (Wong-Kilbourne derivative, clone 1-5c-4 [human conjunctiva], ATCC CCL 20.2) and HeLa cells (human cervical epidermoid carcinoma, ATCC HTB 33) were maintained in minimum essential medium supplemented with nonessential amino acids and 10% (vol/vol) fetal bovine serum. Cells were cultivated at 37°C in 5% CO 2 . Adherence assays were performed as described previously (3, 16, 17) . For adherence inhibition assays, monolayers were preincubated with purified GST fusion proteins for 1.5 h at 37°C in 5% CO 2 prior to inoculation of bacteria. The level of adherence was calculated by dividing the number of adherent CFU per monolayer by the number of inoculated CFU per monolayer. All assays were performed in triplicate, which allowed calculation of means and standard errors. Values were compared to determine statistically significant differences using the two-tailed Student t test.
Detection of protein binding by immunofluorescence microscopy. Immunofluorescence microscopy was performed as described previously (7). Briefly, Chang and HeLa cells were seeded at a density of 8 ϫ 10 4 cells per well onto glass coverslips in 24-well plates, and the plates were incubated overnight. Cell monolayers were washed once with PBS and fixed for 15 min with 2.5% (vol/vol) paraformaldehyde-0.2% (vol/vol) glutaraldehyde in PBS. Monolayers were washed again with PBS, and potentially reactive sites were quenched for 10 min with 20 mM ethanolamine in PBS. Following quenching, nonspecific binding sites were blocked for 30 min with 3% bovine serum albumin in PBS, and cell monolayers were then incubated for 1 h with the relevant purified GST fusion protein at a concentration of 100 nM. Protein binding was detected using an anti-GST antibody (2 g/ml; GE Healthcare) and a Cy2-conjugated secondary antibody (1:200; Jackson Immuno Research). Samples were mounted and examined by confocal scanning microscopy.
Quantitation of protein binding by cellular ELISAs. Enzyme-linked immunosorbent assays (ELISAs) were performed as described previously (7) . Briefly, Chang and HeLa cells were seeded into 96-well tissue culture plates at a density of 1.8 ϫ 10 5 cells per well, and the plates were incubated overnight. Cell monolayers were washed once with PBS and fixed for 15 min with 2.5% (vol/vol) paraformaldehyde-0.2% (vol/vol) glutaraldehyde in PBS. The monolayers were pNS1/HsfBD2 encoding E-to-D mutation at residue 569 in Hsf This study pGEX-6-P-1/HsfBD1 pGEX-6-P-1 containing coding sequence for HsfBD1 from H. influenzae strain C54 3 pGEX-6-P-1/HsfBD2 pGEX-6-P-1 containing coding sequence for HsfBD2 from H. influenzae strain C54 3 pGEX-6-P-1/HsfBD1(Y1934)
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RESULTS

HsfBD1 and HsfBD2 mediate different levels of adherence to HeLa cells.
In previous in vitro studies using purified GST fusion proteins and Chang epithelial cells, we observed that the binding affinity of GST-HsfBD1 was significantly higher than the binding affinity of GST-HsfBD2 when the affinity was assessed by cellular ELISA and immunofluorescence microscopy (3). Despite the difference in binding affinity, E. coli DH5␣ expressing HsfBD1 by itself (in a presentation vector called pNS1) and DH5␣ expressing HsfBD2 by itself adhered to Chang cells at similar levels (3). In the current study, we set out to further characterize the binding properties of HsfBD1 and HsfBD2 and began by examining HsfBD1-and HsfBD2-mediated bacterial adherence to HeLa cells. As shown in Fig. 1A , E. coli DH5␣ expressing HsfBD1 by itself demonstrated highlevel adherence, while E. coli DH5␣ expressing HsfBD2 by itself demonstrated only low-level adherence; thus, these results differed from the results obtained with Chang cells. The low-level adherence associated with HsfBD2 was completely eliminated when the HsfBD2 binding pocket was disrupted via mutagenesis of the residue at position 569 that changed this residue from glutamic acid to alanine (HsfBD2-E569A), paralleling observations with Chang cells and suggesting that the same binding pocket is involved in interactions between HsfBD2 and both HeLa cells and Chang cells (3) .
To determine whether HsfBD1 and HsfBD2 mediate different levels of adherence to HeLa cells in the context of the native Hsf protein, we performed quantitative adherence assays using DH5␣ expressing full-length Hsf with inactivating mutations in the binding pocket of either HsfBD1 or HsfBD2. As shown in Fig. 1B , the adherence levels were consistent with those observed when HsfBD1 and HsfBD2 were expressed by themselves. In particular, the level of adherence remained high when only HsfBD1 was functional (HsfB2 was disrupted) and was low when only HsfBD2 was functional (HsfBD1 was disrupted). Adherence was completely abolished when both HsfBD1 and HsfBD2 were disrupted.
Purified GST-HsfBD1 and GST-HsfBD2 bind to the same host cell receptor on HeLa cells, but the binding affinities are different. To further analyze the interaction of HsfBD1 and HsfBD2 with HeLa cells, we performed cellular ELISAs with purified GST-HsfBD1 and purified GST-HsfBD2. As shown in Fig. 2 , we observed high-affinity binding with GST-HsfBD1 and lower-affinity binding with GST-HsfBD2. As determined with the GraphPad Prism program, the K d for HsfBD1 was ϳ0.2 nM and the K d for HsfBD2 was ϳ3.0 nM, observations similar to our previous observations with Chang cells (3). Consistent with these results, immunofluorescence microscopy revealed that GST-HsfBD1 was associated with strong punctuate fluorescence, while GST-HsfBD2 was associated with only weak fluorescence (Fig. 3A and 3B) .
To extend our findings, we assessed the abilities of purified GST-HsfBD1 and purified GST-HsfBD2 to inhibit Hsf-mediated bacterial adherence to HeLa cells. As shown in Fig. 4A , preincubation of monolayers with GST-HsfBD1 at concentrations as low as 10 nM resulted in complete inhibition of adherence by H. influenzae strain C54b
Ϫ p Ϫ Hsf ϩ , while preincubation with purified GST-HsfBD2 at concentrations of 500 and 300 nM resulted in only partial inhibition of adherence by strain C54b
Ϫ p Ϫ Hsf ϩ , further confirming the different affinities of HsfBD1 and HsfBD2. As shown in Fig. 4B , the concentration of purified GST-HsfBD1 required to inhibit adherence by H. influenzae strain C54b Ϫ p Ϫ Hsf ϩ was lower for HeLa cells than for Chang cells, suggesting that there are different densities of the Hsf host cell receptor in these two cell lines.
To determine whether HsfBD1 and HsfBD2 interact with the same cellular receptor on HeLa cells, we preincubated cell monolayers with purified GST-HsfBD1 and then inoculated monolayers with DH5␣ expressing either HsfBD1 or HsfBD2.
As a control, we preincubated monolayers with purified HMW1, a separate H. influenzae adhesin with a different cell binding specificity. As shown in Fig. 4C , preincubation with 100 nM purified GST-HsfBD1 resulted in complete inhibition of both HsfBD1-and HsfBD2-mediated adherence, while preincubation with purified HMW1 had no effect on adherence. Preincubation with 100 nM purified GST-HsfBD2 completely inhibited HsfBD2-mediated adherence but had no significant effect on HsfBD1-mediated adherence (data not shown). Ϫ p Ϫ Hsf ϩ was inoculated onto monolayers, and adherence was measured with quantitative adherence assays. (C) HeLa cell monolayers were preincubated with 100 nM purified GST-HsfBD1 or purified HMW1 for 90 min. Subsequently, DH5␣ expressing the presentation vector alone, HsfBD1, or HsfBD2 was inoculated onto monolayers, and adherence was measured with quantitative adherence assays. In all panels, adherence is expressed as a percentage of the bacterial inoculum that bound to the epithelial cell monolayers. The bars and error bars indicate the means and standard errors of three measurements from representative experiments. In panel A, the asterisks indicate statistically significant differences (P Ͻ 0.05) for comparisons with H. influenzae C54b Ϫ p Ϫ Hsf ϩ with no inhibitor. In panel B, the asterisks indicate statistically significant differences (P Ͻ 0.05) for comparisons with H. influenzae C54b Ϫ p Ϫ Hsf ϩ with no inhibitor with Chang and HeLa cells. In panel C, the asterisks indicate statistically significant differences (P Ͼ 0.05) between the values indicated by the brackets (e.g., adherence by DH5␣/HsfBD1 was statistically significantly different when monolayers were preincubated with no inhibitor versus GST-HsfBD1).
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densities of the Hsf receptor, we performed flow cytometry using purified GST-HsfBD1 as a probe for receptor molecules and purified GST as a negative control and for measuring background fluorescence. The ratio of the geometric mean fluorescence with GST-HsfBD1 to the geometric mean fluorescence with GST alone was 2.5 for HeLa cells and 8.9 for Chang cells, indicating that there were fewer bound HsfBD1 molecules and hence ϳ70% fewer receptor molecules on HeLa cells than on Chang cells. Homology models of HsfBD1 and HsfBD2 and site-directed mutagenesis. Previous homology models of HsfBD1 and HsfBD2 based on the HiaBD1 structure suggested that there are binding pockets very similar to the binding pocket in HiaBD1 (3) . To refine the homology models of HsfBD1 and HsfBD2, we used both the HiaBD1 structure and the recently solved HiaBD2 structure (9) . As shown in Fig. 5A and 5B, the refined models of HsfBD1 and HsfBD2 share a highly intertwined ␤-meander fold in the Trp-ring domain with HiaBD1 and HiaBD2. Examination of the refined models and alignment of the HsfBD1, HsfBD2, HiaBD1, and HiaBD2 sequences revealed that the binding pocket in HsfBBD1 is formed by residues Y1934, D1935, A1937, V1972, E1985, and E1995 and the binding pocket in HsfBD2 is formed by residues V568, E569, A571, V606, E615, and E625 (Fig. 5C ). Closer inspection revealed two notable differences between the HsfBD1 and HsfBD2 binding pockets; namely, the Y1934 and D1935 residues in HsfBD1 corresponded to V568 and E569 in HsfBD2 (Fig. 5C ). Based on the homology models, both Y1934 and V568 lie in the outermost helix of the structure perpendicular to the threefold axis of the trimer, and both D1935 and E569 lie in a pivotal position initiating a conserved helix-helix kink in the IsNeck domain. While the side chains of Y1934 and V568 point outward away from the trimer, the acidic side chains of D1935 and E569 point inward and appear to be at the center of the binding pocket ( Fig. 5A and 5B).
To assess the role of the Y1934/V568 and D1935/E569 residues in the different binding affinities of HsfBD1 and HsfBD2, we generated individual Y1934V and D1935E mutations in HsfBD1 (inserting the HsfBD2 residues) and individual V568Y and E569D mutations in HsfBD2 (inserting the HsfBD1 residues). As shown in Fig. 6 , DH5␣ expressing HsfBD1 containing the D1935E mutation by itself demonstrated low-level HsfBD2-like adherence, and DH5␣ expressing HsfBD2 containing the E569D mutation by itself demonstrated high-level HsfBD1-like adherence. In contrast, the Y1934V mutation by itself in HsfBD1and the V568Y mutation by itself in HsfBD2 had no effect on adherence.
To confirm the results of the bacterial adherence assays, we generated GST fusion proteins containing individual point mutations in HsfBD1 and HsfBD2 and examined the binding of these proteins by immunofluorescence microscopy. The D1935E mutation alone in HsfBD1 resulted in decreased binding to HeLa cells, similar to binding by GST-HsfBD2 (Fig. 3C) , and the E569D mutation alone in HsfBD2 resulted in increased binding to HeLa cells, similar to binding by GSTHsfBD1 (Fig. 3F) . In contrast, the Y1934V mutation by itself in HsfBD1 and the V568Y mutation by itself in HsfBD2 had no effect on binding (Fig. 3E and 3D, respectively) . 
